PATENT CLAIM ANALYSIS

Application Number: 16396135
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["424", "427000"]

Abstract:
The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.

Claim (Index 1):
An article comprising a compound of formula (A-VIII):\n D1-L-D2\u2003\u2003(A-VIII) or a pharmaceutically acceptable salt thereof, wherein (i) each of D1 and D2 is, independently, a radical formed from a steroid; and L is a linker covalently linking D1 to D2, (ii) at least 70% (w/w) of the article is the compound of formula (A-VIII), (iii) the article is free of controlled release excipient, and (iv) the article is a fiber, pellet, cylinder, hollow tube, microparticle, or a nanoparticle.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.18182
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16396400', '14436657', '15305845', '14651097', '13606949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6775951812515346
- 35 USC 102 Novelty (BERT): 0.5363517103728281
- Combined Prediction Score: 0.6634708341636639
- Mean Citation Score: 231.399632
- Max Citation Score: 347.4539200000001
- Similarity Product: 210.2929026042844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test